Sefaxersen sodium

N/A

Report date: 2025/12/22 10:33:04
NME

Base Information

Drug NameSefaxersen sodium
Drug Alias NameIONIS-FB-LRxISIS-GSK4RxISIS-696844ISIS-GSK4-LRxIONIS-GSK4-LRx +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsGlomerulonephritis, IGAGeographic AtrophyMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncF. Hoffmann-La Roche AgF. Hoffmann-La Roche Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGAGeographic AtrophyMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A